enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. US FDA approves Elanco's skin disease treatment for dogs - AOL

   www.aol.com/news/us-fda-approves-elancos-skin...

   The FDA approval for Zenrelia carries a boxed warning stating that dogs should not be vaccinated at least 28 days before and after treatment with the drug, due to the risk of fatal vaccine-induced ...

3. Skin conditions in dogs: Symptoms, causes, and how to help - AOL

   www.aol.com/skin-conditions-dogs-symptoms-causes...

   Parasites: Treatment. Once an infestation begins, many pet parents struggle with how to get rid of fleas.Dr. MacMillan recommends using a vet-approved anti-parasite product, treating your home ...

4. Oclacitinib - Wikipedia

   en.wikipedia.org/wiki/Oclacitinib

   Most of the other contraindications are avoiding cases where a potential side effect exacerbates a pre-existing condition: for example, because oclacitinib can cause lumps or tumors, it should not be used in dogs with cancer or a history of it; [15] because it is an immune system suppressant, it should not be used in dogs with serious infections.

5. Cefovecin - Wikipedia

   en.wikipedia.org/wiki/Cefovecin

   Cefovecin is an antibiotic of the cephalosporin class, licensed for the treatment of skin infections in cats and dogs. It is marketed by Zoetis under the trade name Convenia. It is used to treat skin infections caused by Pasteurella multocida in cats, and Staphylococcus intermedius and Streptococcus canis in dogs. The advantage of using a long ...

6. Lokivetmab - Wikipedia

   en.wikipedia.org/wiki/Lokivetmab

   Lokivetmab, trade name Cytopoint, is a monoclonal antibody used to treat atopic dermatitis in dogs. [1] It acts against interleukin 31 (IL-31), [2] which is a cytokine involved in causing itchiness (pruritus). [2] Lokivetmab is administered by subcutaneous injection; each dose is effective for four to eight weeks. [3]

7. FDA Approves APOQUEL® (oclacitinib tablet) to Control Itch ...

   www.aol.com/news/2013-05-16-fda-approves-apoquel...

   MADISON, N.J.--(BUSINESS WIRE)-- Zoetis, Inc. (NYS: ZTS) , formerly the animal health business unit of Pfizer Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved ...